JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NTUS
2226
DELISTED
Natus Medical Inc
NTUS
| $7.74M | ﹤0.01% |
202,564
+164,797
| +436% | +$6.58M |
2013 Q2
18 quarters
|
|
2227
Stepan Co
SCL
$1.42B
| $7.74M | ﹤0.01% |
97,952
+19
| +0% | +$1.56K |
2013 Q2
18 quarters
|
|
|
CUTR
2228
DELISTED
Cutera, Inc.
CUTR
| $7.72M | ﹤0.01% |
170,174
+21,374
| +14% | +$902K |
2016 Q4
4 quarters
|
|
2229
PUT
FedEx
FDX
$67.9B
| $7.71M | ﹤0.01% |
30,900
+30,200
| +4,314% | +$6.91M |
2016 Q4
4 quarters
|
|
2230
CALL
The Mosaic Company
MOS
$6.85B
| $7.7M | ﹤0.01% |
300,000
+100,000
| +50% | +$2.3M |
2017 Q3
1 quarter
|
|
2231
Mattel
MAT
$4.3B
| $7.7M | ﹤0.01% |
500,477
-17,385
| -3% | -$276K |
2013 Q2
18 quarters
|
|
2232
Golar LNG
GLNG
$4.93B
| $7.7M | ﹤0.01% |
258,156
+4,646
| +2% | +$112K |
2013 Q2
18 quarters
|
|
2233
WisdomTree US MidCap Dividend Fund
DON
$3.78B
| $7.69M | ﹤0.01% |
217,861
-200
| -0.1% | -$6.84K |
2013 Q2
18 quarters
|
|
|
MNK
2234
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $7.67M | ﹤0.01% |
340,000
| – | – |
2017 Q3
1 quarter
|
|
2235
PUT
Eastman Chemical
EMN
$7.32B
| $7.65M | ﹤0.01% |
82,600
+14,100
| +21% | +$1.28M |
2017 Q1
3 quarters
|
|
|
TIVO
2236
PUT
DELISTED
Tivo Inc
TIVO
| $7.64M | ﹤0.01% |
+490,000
| New | +$8.48M |
2017 Q4
0 quarters
|
|
2237
CALL
Marriott International
MAR
$92.5B
| $7.64M | ﹤0.01% |
56,300
-15,700
| -22% | -$1.93M |
2016 Q4
4 quarters
|
|
|
BPY
2238
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $7.64M | ﹤0.01% |
344,586
+344,252
| +103,069% | +$7.86M |
2015 Q4
8 quarters
|
|
2239
Dime Commercial Bancshares
DCOM
$1.75B
| $7.63M | ﹤0.01% |
218,019
+1,132
| +0.5% | +$39.5K |
2013 Q2
18 quarters
|
|
|
ORBK
2240
DELISTED
Orbotech Ltd
ORBK
| $7.62M | ﹤0.01% |
151,692
-994,727
| -87% | -$48.4M |
2016 Q1
7 quarters
|
|
2241
CALL
Viatris
VTRS
$20.1B
| $7.62M | ﹤0.01% |
180,000
| – | – |
2017 Q1
3 quarters
|
|
2242
PUT
Alcoa
AA
$11.1B
| $7.6M | ﹤0.01% |
+141,000
| New | +$6.45M |
2017 Q4
0 quarters
|
|
|
NXRT
2243
NexPoint Residential Trust
NXRT
$482M
| $7.58M | ﹤0.01% |
271,458
+13,602
| +5% | +$360K |
2015 Q4
8 quarters
|
|
|
GRA
2244
CALL
DELISTED
W.R. Grace & Co.
GRA
| $7.58M | ﹤0.01% |
108,100
+5,900
| +6% | +$427K |
2017 Q3
1 quarter
|
|
2245
Grand Canyon Education
LOPE
$4.01B
| $7.56M | ﹤0.01% |
84,483
+16,614
| +24% | +$1.5M |
2015 Q4
8 quarters
|
|
|
AVXS
2246
DELISTED
AveXis, Inc. Common Stock
AVXS
| $7.56M | ﹤0.01% |
68,340
+13,279
| +24% | +$1.33M |
2016 Q1
7 quarters
|
|
2247
iShares US Financials ETF
IYF
$3.92B
| $7.55M | ﹤0.01% |
126,404
-8,136
| -6% | -$472K |
2013 Q2
18 quarters
|
|
|
NSL
2248
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $7.54M | ﹤0.01% |
1,158,717
| – | – |
2013 Q2
18 quarters
|
|
|
CHK
2249
DELISTED
Chesapeake Energy Corporation
CHK
| $7.53M | ﹤0.01% |
9,504
+120
| +1% | +$93.5K |
2013 Q2
18 quarters
|
|
2250
Oceaneering
OII
$4.42B
| $7.52M | ﹤0.01% |
355,968
+139,090
| +64% | +$2.96M |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.